<!--
  ArcaScience Case Study: Novartis — AI-Powered PSUR Automation Across the Portfolio
  ============================================================
  This file follows the exact structural blueprint of case-study.html.
  All classes use the arca-* prefix. Data-attributes trigger JS behaviors.
  Evidence nav link is-active on this page.
-->

<!DOCTYPE html>
<html lang="en" data-arca>
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>AI-Powered PSUR Automation Across the Portfolio — Novartis — ArcaScience Case Study</title>
  <meta name="description" content="How ArcaScience helped Novartis automate PSUR/PBRER generation across 300+ products. 60% reduction in preparation time, zero regulatory deadline misses, $12M annual savings.">

  <!-- Fonts: self-hosted for performance -->
  <link rel="preload" href="/fonts/Inter-Variable.woff2" as="font" type="font/woff2" crossorigin>
  <link rel="preload" href="/fonts/Literata-Variable.woff2" as="font" type="font/woff2" crossorigin>

  <!-- Global CSS (from build) -->
  <link rel="stylesheet" href="/dist/arcascience-global.min.css">

  <!-- Reduced motion detection before paint -->
  <script>
    (function(){
      if(window.matchMedia&&window.matchMedia('(prefers-reduced-motion: reduce)').matches){
        document.documentElement.classList.add('reduced-motion');
      }
    })();
  </script>
</head>
<body>

  <!-- ================================================================
       SCROLL PROGRESS BAR
       ================================================================ -->
  <div data-scroll-progress></div>

  <!-- ================================================================
       NAVIGATION
       ================================================================ -->
  <nav class="arca-nav" data-nav="sticky" role="navigation" aria-label="Main navigation">
    <div style="max-width: var(--content-max-width); margin: 0 auto; padding: 0 24px; display: flex; align-items: center; justify-content: space-between; height: 100%;">

      <!-- Logo -->
      <a href="/" aria-label="ArcaScience home">
        <img src="/images/arcascience-logo.svg" alt="ArcaScience" height="32">
      </a>

      <!-- Nav Links -->
      <div style="display: flex; align-items: center; gap: 32px;">
        <a href="/" class="arca-nav-link">Home</a>

        <!-- Platform dropdown -->
        <div style="position: relative;" class="arca-nav-dropdown-wrap">
          <a href="/platform-overview" class="arca-nav-link">Platform <svg width="10" height="6" viewBox="0 0 10 6" fill="none" style="margin-left: 4px; vertical-align: middle;"><path d="M1 1L5 5L9 1" stroke="currentColor" stroke-width="1.5" stroke-linecap="round" stroke-linejoin="round"/></svg></a>
          <div class="arca-nav-dropdown" style="position: absolute; top: 100%; left: -12px; min-width: 260px; padding: 8px 0; background: rgba(255,255,255,0.97); backdrop-filter: blur(12px); -webkit-backdrop-filter: blur(12px); border: 1px solid rgba(209,213,222,0.5); border-radius: 12px; box-shadow: 0 4px 12px rgba(0,0,0,0.06), 0 12px 32px rgba(0,0,0,0.08); opacity: 0; visibility: hidden; transform: translateY(-8px); transition: opacity 200ms ease, transform 200ms ease, visibility 200ms; z-index: 100;">
            <a href="/platform-overview" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Platform Overview</a>
            <a href="/platform-how-it-works" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">How It Works</a>
            <a href="/platform-data-intelligence" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Data Intelligence</a>
            <a href="/platform-ai-models" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">AI Models</a>
            <a href="/platform-outputs" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Regulatory Outputs</a>
            <a href="/platform-integrations" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Integrations</a>
            <div style="height: 1px; background: linear-gradient(90deg, transparent, rgba(35,86,160,0.15), transparent); margin: 6px 12px;"></div>
            <a href="/security-compliance" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Security &amp; Compliance</a>
          </div>
        </div>

        <!-- Solutions dropdown -->
        <div style="position: relative;" class="arca-nav-dropdown-wrap">
          <a href="/solution-therapeutic-area" class="arca-nav-link">Solutions <svg width="10" height="6" viewBox="0 0 10 6" fill="none" style="margin-left: 4px; vertical-align: middle;"><path d="M1 1L5 5L9 1" stroke="currentColor" stroke-width="1.5" stroke-linecap="round" stroke-linejoin="round"/></svg></a>
          <div class="arca-nav-dropdown" style="position: absolute; top: 100%; left: -12px; min-width: 260px; padding: 8px 0; background: rgba(255,255,255,0.97); backdrop-filter: blur(12px); -webkit-backdrop-filter: blur(12px); border: 1px solid rgba(209,213,222,0.5); border-radius: 12px; box-shadow: 0 4px 12px rgba(0,0,0,0.06), 0 12px 32px rgba(0,0,0,0.08); opacity: 0; visibility: hidden; transform: translateY(-8px); transition: opacity 200ms ease, transform 200ms ease, visibility 200ms; z-index: 100;">
            <p style="padding: 6px 16px 4px; font-size: 0.6875rem; font-weight: 600; letter-spacing: 0.08em; text-transform: uppercase; color: var(--grey-400); margin: 0;">By Approach</p>
            <a href="/solution-therapeutic-area" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">By Therapeutic Area</a>
            <a href="/solution-lifecycle-phase" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">By Lifecycle Phase</a>
            <a href="/solution-role" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">By Role</a>
            <div style="height: 1px; background: linear-gradient(90deg, transparent, rgba(35,86,160,0.15), transparent); margin: 6px 12px;"></div>
            <p style="padding: 6px 16px 4px; font-size: 0.6875rem; font-weight: 600; letter-spacing: 0.08em; text-transform: uppercase; color: var(--grey-400); margin: 0;">By Stage</p>
            <a href="/solution-early-development" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Early Development</a>
            <a href="/solution-late-development" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Late Development</a>
            <a href="/solution-post-marketing" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Post-Marketing</a>
            <a href="/solution-market-access" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Market Access</a>
            <div style="height: 1px; background: linear-gradient(90deg, transparent, rgba(35,86,160,0.15), transparent); margin: 6px 12px;"></div>
            <p style="padding: 6px 16px 4px; font-size: 0.6875rem; font-weight: 600; letter-spacing: 0.08em; text-transform: uppercase; color: var(--grey-400); margin: 0;">Therapeutic Areas</p>
            <a href="/ta-oncology" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Oncology</a>
            <a href="/ta-neurology" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Neurology</a>
            <a href="/ta-immunology" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Immunology</a>
            <a href="/ta-cardiology" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Cardiology</a>
            <a href="/ta-respiratory" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Respiratory</a>
            <a href="/ta-rare-diseases" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Rare Diseases</a>
            <a href="/ta-dermatology" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Dermatology</a>
            <a href="/ta-hematology" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Hematology</a>
            <a href="/ta-gastroenterology" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Gastroenterology</a>
            <a href="/ta-endocrinology" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Endocrinology</a>
            <a href="/ta-infectious-disease" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Infectious Disease</a>
            <a href="/ta-pediatrics" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Pediatrics</a>
          </div>
        </div>


        <div style="position: relative;" class="arca-nav-dropdown-wrap">
          <a href="/evidence-case-studies-hub" class="arca-nav-link is-active">Evidence <svg width="10" height="6" viewBox="0 0 10 6" fill="none" style="margin-left: 4px; vertical-align: middle;"><path d="M1 1L5 5L9 1" stroke="currentColor" stroke-width="1.5" stroke-linecap="round" stroke-linejoin="round"/></svg></a>
          <div class="arca-nav-dropdown" style="position: absolute; top: 100%; left: -12px; min-width: 220px; padding: 8px 0; background: rgba(255,255,255,0.97); backdrop-filter: blur(12px); -webkit-backdrop-filter: blur(12px); border: 1px solid rgba(209,213,222,0.5); border-radius: 12px; box-shadow: 0 4px 12px rgba(0,0,0,0.06), 0 12px 32px rgba(0,0,0,0.08); opacity: 0; visibility: hidden; transform: translateY(-8px); transition: opacity 200ms ease, transform 200ms ease, visibility 200ms; z-index: 100;">
            <a href="/evidence-case-studies-hub" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Case Studies</a>
            <a href="/evidence-publications" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Publications</a>
            <a href="/evidence-metrics" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Platform Metrics</a>
          </div>
        </div>
        <div style="position: relative;" class="arca-nav-dropdown-wrap">
          <a href="/about" class="arca-nav-link">Company <svg width="10" height="6" viewBox="0 0 10 6" fill="none" style="margin-left: 4px; vertical-align: middle;"><path d="M1 1L5 5L9 1" stroke="currentColor" stroke-width="1.5" stroke-linecap="round" stroke-linejoin="round"/></svg></a>
          <div class="arca-nav-dropdown" style="position: absolute; top: 100%; left: -12px; min-width: 200px; padding: 8px 0; background: rgba(255,255,255,0.97); backdrop-filter: blur(12px); -webkit-backdrop-filter: blur(12px); border: 1px solid rgba(209,213,222,0.5); border-radius: 12px; box-shadow: 0 4px 12px rgba(0,0,0,0.06), 0 12px 32px rgba(0,0,0,0.08); opacity: 0; visibility: hidden; transform: translateY(-8px); transition: opacity 200ms ease, transform 200ms ease, visibility 200ms; z-index: 100;">
            <a href="/about" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">About ArcaScience</a>
            <a href="/leadership" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Leadership</a>
            <a href="/careers" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Careers</a>
            <a href="/science-methodology" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Science &amp; Methodology</a>
          </div>
        </div>
        <div style="position: relative;" class="arca-nav-dropdown-wrap">
          <a href="/resources" class="arca-nav-link">Resources <svg width="10" height="6" viewBox="0 0 10 6" fill="none" style="margin-left: 4px; vertical-align: middle;"><path d="M1 1L5 5L9 1" stroke="currentColor" stroke-width="1.5" stroke-linecap="round" stroke-linejoin="round"/></svg></a>
          <div class="arca-nav-dropdown" style="position: absolute; top: 100%; right: -12px; min-width: 220px; padding: 8px 0; background: rgba(255,255,255,0.97); backdrop-filter: blur(12px); -webkit-backdrop-filter: blur(12px); border: 1px solid rgba(209,213,222,0.5); border-radius: 12px; box-shadow: 0 4px 12px rgba(0,0,0,0.06), 0 12px 32px rgba(0,0,0,0.08); opacity: 0; visibility: hidden; transform: translateY(-8px); transition: opacity 200ms ease, transform 200ms ease, visibility 200ms; z-index: 100;">
            <a href="/resources" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Resource Hub</a>
            <a href="/resources-whitepapers" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Whitepapers</a>
            <a href="/resources-webinars" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Webinars &amp; Events</a>
            <div style="height: 1px; background: linear-gradient(90deg, transparent, rgba(35,86,160,0.15), transparent); margin: 6px 12px;"></div>
            <a href="/resources-faq" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">FAQ</a>
            <a href="/resources-glossary" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Glossary</a>
          </div>
        </div>
      </div>

      <!-- Header CTA -->
      <a href="/contact" class="arca-btn-primary" style="height: 40px; padding: 8px 24px; font-size: 0.875rem;">
        Talk to a Scientist
      </a>
    </div>
  </nav>

  <!-- Spacer for fixed nav -->
  <div style="height: var(--nav-height);"></div>

  <main role="main">

    <!-- ================================================================
         SECTION 1: BREADCRUMB
         ================================================================ -->
    <section style="padding: var(--space-5) 0 0;">
      <div style="max-width: var(--content-max-width); margin: 0 auto; padding: 0 24px;">
        <nav aria-label="Breadcrumb">
          <ol style="list-style: none; padding: 0; margin: 0; display: flex; align-items: center; gap: 8px; font-size: 0.75rem;">
            <li><a href="/" style="color: var(--grey-600); text-decoration: none;">Home</a></li>
            <li style="color: var(--grey-400);">/</li>
            <li><a href="/evidence-case-studies-hub" style="color: var(--grey-600); text-decoration: none;">Evidence</a></li>
            <li style="color: var(--grey-400);">/</li>
            <li><a href="/evidence-case-studies-hub" style="color: var(--grey-600); text-decoration: none;">Case Studies</a></li>
            <li style="color: var(--grey-400);">/</li>
            <li style="color: var(--grey-900);">Novartis: AI-Powered PSUR Automation Across the Portfolio</li>
          </ol>
        </nav>
      </div>
    </section>

    <!-- ================================================================
         SECTION 2: HERO
         ================================================================ -->
    <section class="arca-bg-blue-900" style="position: relative; overflow: hidden; padding: var(--space-8) 0 var(--space-9);" data-animate>
<!-- arca-decor-injected -->
      <!-- arca-decor: glow orbs -->
      <div style="position: absolute; top: -100px; right: -100px; width: 500px; height: 500px; background: radial-gradient(circle, rgba(22, 128, 60, 0.10) 0%, transparent 70%); border-radius: 50%; filter: blur(60px); pointer-events: none; animation: as-float 8s ease-in-out infinite; z-index: 0;"></div>
      <div style="position: absolute; bottom: -80px; left: -80px; width: 400px; height: 400px; background: radial-gradient(circle, rgba(13, 124, 107, 0.06) 0%, transparent 70%); border-radius: 50%; filter: blur(60px); pointer-events: none; animation: as-float 10s ease-in-out infinite reverse; z-index: 0;"></div>

    <!-- arca-decor: evidence chart SVG -->
    <svg width="380" height="280" viewBox="0 0 380 280" fill="none" aria-hidden="true" style="position: absolute; right: -10px; top: 50%; transform: translateY(-50%); opacity: 0.1; pointer-events: none; z-index: 0;">
      <rect x="60" y="40" width="280" height="200" rx="6" stroke="rgba(22,128,60,0.3)" stroke-width="1" fill="none"/>
      <line x1="90" y1="200" x2="310" y2="200" stroke="rgba(22,128,60,0.2)" stroke-width="1"/>
      <line x1="90" y1="160" x2="310" y2="160" stroke="rgba(22,128,60,0.08)" stroke-width="1" stroke-dasharray="4 4"/>
      <line x1="90" y1="120" x2="310" y2="120" stroke="rgba(22,128,60,0.08)" stroke-width="1" stroke-dasharray="4 4"/>
      <line x1="90" y1="80" x2="310" y2="80" stroke="rgba(22,128,60,0.08)" stroke-width="1" stroke-dasharray="4 4"/>
      <polyline points="100,180 140,150 180,160 220,110 260,90 300,70" stroke="rgba(22,128,60,0.4)" stroke-width="2" fill="none" stroke-linecap="round" stroke-linejoin="round"/>
      <polyline points="100,190 140,170 180,175 220,140 260,130 300,120" stroke="rgba(13,124,107,0.3)" stroke-width="1.5" fill="none" stroke-dasharray="6 3" stroke-linecap="round"/>
      <circle cx="220" cy="110" r="4" fill="rgba(22,128,60,0.4)"/>
      <circle cx="300" cy="70" r="4" fill="rgba(22,128,60,0.5)"/>
    </svg>

      <div style="position: relative; z-index: 1; max-width: var(--content-max-width); margin: 0 auto; padding: 0 24px;">

        <!-- Client logo placeholder -->
        <div style="margin-bottom: var(--space-6); text-align: center;">
          <img src="/images/logos/novartis-logo.svg" alt="Novartis logo" style="height: 48px; filter: brightness(0) invert(1); opacity: 0.9;">
        </div>

        <!-- Hero image: Inline SVG — document grid with checkmarks for portfolio PSUR automation -->
        <div style="max-width: 680px; margin: 0 auto var(--space-6); border-radius: 8px; overflow: hidden; box-shadow: 0 8px 32px rgba(0,0,0,0.3);">
          <svg viewBox="0 0 680 383" fill="none" xmlns="http://www.w3.org/2000/svg" role="img" aria-label="Novartis portfolio PSUR automation document grid visualization" style="width: 100%; display: block;">
            <defs>
              <linearGradient id="nv-hero-bg" x1="0" y1="0" x2="680" y2="383" gradientUnits="userSpaceOnUse">
                <stop offset="0%" stop-color="#141D35"/><stop offset="50%" stop-color="#1A2845"/><stop offset="100%" stop-color="#162040"/>
              </linearGradient>
            </defs>
            <rect width="680" height="383" fill="url(#nv-hero-bg)"/>
            <!-- Row 1: 6 document icons -->
            <rect x="50" y="35" width="70" height="90" rx="4" stroke="#B45309" stroke-width="1" fill="#B45309" opacity="0.1"/>
            <rect x="60" y="52" width="32" height="3" rx="1" fill="#B45309" opacity="0.25"/><rect x="60" y="60" width="24" height="3" rx="1" fill="#B45309" opacity="0.2"/>
            <path d="M102 102 L107 107 L117 93" stroke="#B45309" stroke-width="2.5" stroke-linecap="round" stroke-linejoin="round" opacity="0.6"/>

            <rect x="150" y="35" width="70" height="90" rx="4" stroke="#3B7DD8" stroke-width="1" fill="#3B7DD8" opacity="0.1"/>
            <rect x="160" y="52" width="32" height="3" rx="1" fill="#3B7DD8" opacity="0.25"/><rect x="160" y="60" width="24" height="3" rx="1" fill="#3B7DD8" opacity="0.2"/>
            <path d="M202 102 L207 107 L217 93" stroke="#3B7DD8" stroke-width="2.5" stroke-linecap="round" stroke-linejoin="round" opacity="0.6"/>

            <rect x="250" y="35" width="70" height="90" rx="4" stroke="#B45309" stroke-width="1" fill="#B45309" opacity="0.1"/>
            <rect x="260" y="52" width="32" height="3" rx="1" fill="#B45309" opacity="0.25"/><rect x="260" y="60" width="24" height="3" rx="1" fill="#B45309" opacity="0.2"/>
            <path d="M302 102 L307 107 L317 93" stroke="#B45309" stroke-width="2.5" stroke-linecap="round" stroke-linejoin="round" opacity="0.6"/>

            <rect x="350" y="35" width="70" height="90" rx="4" stroke="#3B7DD8" stroke-width="1" fill="#3B7DD8" opacity="0.1"/>
            <rect x="360" y="52" width="32" height="3" rx="1" fill="#3B7DD8" opacity="0.25"/><rect x="360" y="60" width="24" height="3" rx="1" fill="#3B7DD8" opacity="0.2"/>
            <path d="M402 102 L407 107 L417 93" stroke="#3B7DD8" stroke-width="2.5" stroke-linecap="round" stroke-linejoin="round" opacity="0.6"/>

            <rect x="450" y="35" width="70" height="90" rx="4" stroke="#B45309" stroke-width="1" fill="#B45309" opacity="0.1"/>
            <rect x="460" y="52" width="32" height="3" rx="1" fill="#B45309" opacity="0.25"/><rect x="460" y="60" width="24" height="3" rx="1" fill="#B45309" opacity="0.2"/>
            <path d="M502 102 L507 107 L517 93" stroke="#B45309" stroke-width="2.5" stroke-linecap="round" stroke-linejoin="round" opacity="0.6"/>

            <rect x="550" y="35" width="70" height="90" rx="4" stroke="#3B7DD8" stroke-width="1" fill="#3B7DD8" opacity="0.1"/>
            <rect x="560" y="52" width="32" height="3" rx="1" fill="#3B7DD8" opacity="0.25"/><rect x="560" y="60" width="24" height="3" rx="1" fill="#3B7DD8" opacity="0.2"/>
            <path d="M602 102 L607 107 L617 93" stroke="#3B7DD8" stroke-width="2.5" stroke-linecap="round" stroke-linejoin="round" opacity="0.6"/>

            <!-- Row 2: 6 document icons (some in progress) -->
            <rect x="50" y="150" width="70" height="90" rx="4" stroke="#3B7DD8" stroke-width="1" fill="#3B7DD8" opacity="0.1"/>
            <rect x="60" y="167" width="32" height="3" rx="1" fill="#3B7DD8" opacity="0.25"/><rect x="60" y="175" width="24" height="3" rx="1" fill="#3B7DD8" opacity="0.2"/>
            <path d="M102 217 L107 222 L117 208" stroke="#3B7DD8" stroke-width="2.5" stroke-linecap="round" stroke-linejoin="round" opacity="0.6"/>

            <rect x="150" y="150" width="70" height="90" rx="4" stroke="#B45309" stroke-width="1" fill="#B45309" opacity="0.1"/>
            <rect x="160" y="167" width="32" height="3" rx="1" fill="#B45309" opacity="0.25"/><rect x="160" y="175" width="24" height="3" rx="1" fill="#B45309" opacity="0.2"/>
            <path d="M202 217 L207 222 L217 208" stroke="#B45309" stroke-width="2.5" stroke-linecap="round" stroke-linejoin="round" opacity="0.6"/>

            <rect x="250" y="150" width="70" height="90" rx="4" stroke="#3B7DD8" stroke-width="1" fill="#3B7DD8" opacity="0.08"/>
            <rect x="260" y="167" width="32" height="3" rx="1" fill="#3B7DD8" opacity="0.2"/><rect x="260" y="175" width="24" height="3" rx="1" fill="#3B7DD8" opacity="0.15"/>
            <circle cx="290" cy="215" r="10" fill="none" stroke="#B45309" stroke-width="1.5" opacity="0.35" stroke-dasharray="4 3"/>

            <rect x="350" y="150" width="70" height="90" rx="4" stroke="#B45309" stroke-width="1" fill="#B45309" opacity="0.06"/>
            <rect x="360" y="167" width="32" height="3" rx="1" fill="#B45309" opacity="0.15"/><rect x="360" y="175" width="24" height="3" rx="1" fill="#B45309" opacity="0.1"/>

            <rect x="450" y="150" width="70" height="90" rx="4" stroke="#3B7DD8" stroke-width="1" fill="#3B7DD8" opacity="0.05"/>
            <rect x="460" y="167" width="32" height="3" rx="1" fill="#3B7DD8" opacity="0.12"/><rect x="460" y="175" width="24" height="3" rx="1" fill="#3B7DD8" opacity="0.08"/>

            <rect x="550" y="150" width="70" height="90" rx="4" stroke="#B45309" stroke-width="1" fill="#B45309" opacity="0.04"/>
            <rect x="560" y="167" width="32" height="3" rx="1" fill="#B45309" opacity="0.1"/><rect x="560" y="175" width="24" height="3" rx="1" fill="#B45309" opacity="0.06"/>

            <!-- Row 3 (faded, suggesting scale) -->
            <rect x="50" y="265" width="70" height="90" rx="4" stroke="#B45309" stroke-width="0.5" fill="#B45309" opacity="0.03"/>
            <rect x="150" y="265" width="70" height="90" rx="4" stroke="#3B7DD8" stroke-width="0.5" fill="#3B7DD8" opacity="0.03"/>
            <rect x="250" y="265" width="70" height="90" rx="4" stroke="#B45309" stroke-width="0.5" fill="#B45309" opacity="0.025"/>
            <rect x="350" y="265" width="70" height="90" rx="4" stroke="#3B7DD8" stroke-width="0.5" fill="#3B7DD8" opacity="0.025"/>
            <rect x="450" y="265" width="70" height="90" rx="4" stroke="#B45309" stroke-width="0.5" fill="#B45309" opacity="0.02"/>
            <rect x="550" y="265" width="70" height="90" rx="4" stroke="#3B7DD8" stroke-width="0.5" fill="#3B7DD8" opacity="0.02"/>
          </svg>
        </div>

        <div style="max-width: 840px; margin: 0 auto; text-align: center;">
          <h1 class="arca-display-lg arca-text-white" style="margin-bottom: var(--space-5);">
            Novartis: AI-Powered PSUR Automation Across the Portfolio
          </h1>

          <!-- Tag pills -->
          <div style="display: flex; gap: 12px; justify-content: center; flex-wrap: wrap;">
            <span class="arca-module-tag is-analytics" style="background: rgba(255,255,255,0.15); color: var(--white); border: 1px solid rgba(255,255,255,0.2);">
              Cross-Therapeutic
            </span>
            <span class="arca-module-tag is-data" style="background: rgba(255,255,255,0.15); color: var(--white); border: 1px solid rgba(255,255,255,0.2);">
              Post-Marketing
            </span>
            <span class="arca-module-tag is-data" style="background: rgba(255,255,255,0.15); color: var(--white); border: 1px solid rgba(255,255,255,0.2);">
              Market Access
            </span>
            <span class="arca-module-tag is-output" style="background: rgba(255,255,255,0.15); color: var(--white); border: 1px solid rgba(255,255,255,0.2);">
              PSUR / PBRER Automation
            </span>
          </div>
        </div>

      </div>
    </section>

    <!-- ================================================================
         SECTION 3: KEY RESULTS BAR
         ================================================================ -->
    <section class="arca-credibility-bar" style="background: var(--blue-600); padding: var(--space-7) 0;" data-animate>
      <div style="max-width: var(--content-max-width); margin: 0 auto; padding: 0 24px;">
        <div style="display: grid; grid-template-columns: repeat(4, 1fr); gap: 32px; text-align: center;">

          <div class="arca-credibility-metric">
            <span class="arca-stat-lg" data-countup="60" data-countup-suffix="%">60%</span>
            <p class="arca-caption">Reduction in PSUR preparation time</p>
          </div>

          <div class="arca-credibility-metric">
            <span class="arca-stat-lg" data-countup="0" data-countup-prefix="" data-countup-suffix="">0</span>
            <p class="arca-caption">Regulatory deadline misses</p>
          </div>

          <div class="arca-credibility-metric">
            <span class="arca-stat-lg" data-countup="12" data-countup-prefix="$" data-countup-suffix="M">$12M</span>
            <p class="arca-caption">Annual cost savings</p>
          </div>

          <div class="arca-credibility-metric">
            <span class="arca-stat-lg" data-countup="300" data-countup-suffix="+">300+</span>
            <p class="arca-caption">Products covered by automation</p>
          </div>

        </div>
      </div>
    </section>

    <!-- ================================================================
         SECTION 4: OVERVIEW
         ================================================================ -->
    <section style="padding: var(--space-9) 0;" data-animate>
      <div style="max-width: var(--content-max-width); margin: 0 auto; padding: 0 24px;">
        <div style="max-width: 680px; margin: 0 auto;">
          <h2 class="arca-heading-1" style="margin-bottom: var(--space-5);">
            Overview
          </h2>
          <div class="arca-body-lg" style="color: var(--grey-700); line-height: 1.75;">
            <p>Novartis is one of the world's largest pharmaceutical companies, with a marketed portfolio spanning more than 300 active products across oncology (Kisqali, Pluvicto, Scemblix), immunology (Cosentyx, Kesimpta), cardiovascular (Entresto, Leqvio), neuroscience (Aimovig, Mayzent), ophthalmology (Lucentis, Beovu), and gene therapy (Zolgensma). This breadth of portfolio generates one of the highest volumes of periodic safety reporting obligations in the industry.</p>
            <p>Novartis's Global Drug Safety (GDS) organization was producing more than 150 Periodic Safety Update Reports (PSURs) and Periodic Benefit-Risk Evaluation Reports (PBRERs) annually, each requiring 6 to 8 weeks of manual effort by cross-functional teams of pharmacovigilance scientists, medical writers, biostatisticians, and regulatory affairs professionals. The cumulative operational burden was consuming the equivalent of 85 full-time employees annually and costing an estimated $20M per year in direct labor and external vendor fees.</p>
            <p>ArcaScience partnered with Novartis to deploy a portfolio-wide PSUR automation platform that transformed the periodic reporting process from a labor-intensive manual exercise into a streamlined, AI-assisted workflow with continuous signal monitoring and automated document generation.</p>
          </div>
        </div>
      </div>
    </section>

    <!-- ================================================================
         SECTION 5: THE CHALLENGE
         ================================================================ -->
    <div class="arca-section-divider" aria-hidden="true"></div>

    <section style="padding: var(--space-9) 0;" data-animate>
      <div style="max-width: var(--content-max-width); margin: 0 auto; padding: 0 24px;">
        <div style="max-width: 680px; margin: 0 auto;">
          <h2 class="arca-heading-1" style="margin-bottom: var(--space-5);">
            The Challenge
          </h2>
          <div class="arca-body-lg" style="color: var(--grey-700); line-height: 1.75;">
            <p>The scale and complexity of Novartis's periodic reporting obligations presented challenges that no incremental process improvement could solve:</p>
            <p><strong>Massive volume with rigid deadlines.</strong> With 150+ PSURs due annually, Novartis's GDS organization was operating in a near-continuous state of PSUR production. The EMA's fixed International Birth Date (IBD) schedule and EURD list requirements meant that deadline compression was not an option. A single missed deadline could trigger regulatory non-compliance proceedings, risk management plan modifications, or in extreme cases, marketing authorization variations. In the 18 months prior to the ArcaScience engagement, two PSURs had been submitted with less than 48 hours of margin, requiring emergency weekend staffing to avoid deadline breaches.</p>
            <p><strong>Inconsistent quality across therapeutic areas.</strong> Each therapeutic area team had developed its own PSUR preparation workflows, resulting in significant variation in analytical depth, formatting, and benefit-risk presentation. The oncology team's PSURs for Kisqali and Pluvicto used quantitative MCDA-based benefit-risk frameworks, while the cardiovascular team's PSURs for Entresto relied primarily on qualitative assessments. EMA PRAC assessors had noted this inconsistency, with assessment reports for three products in the immunology portfolio requesting "more structured and quantitative benefit-risk evaluation" in the most recent cycle.</p>
            <p><strong>Resource-intensive data compilation.</strong> Each PSUR required data extraction from Novartis's Argus safety database, clinical trial databases (Novartis Clinical Trial Results Database), published literature (PubMed, Embase), post-authorization safety studies, and risk management plan effectiveness data. For high-volume products like Cosentyx (secukinumab), with over 300,000 patient-years of exposure, the data compilation phase alone consumed 3 to 4 weeks of a pharmacovigilance scientist's time. Manual line listing generation, tabulation of adverse events by System Organ Class, and interval/cumulative summary calculations were repeated identically for each reporting period.</p>
            <p><strong>Signal detection fragmentation.</strong> Signal detection activities were performed separately from PSUR preparation, often by different teams. The signal management team used empirica Signal for disproportionality analysis on the Argus database, while PSUR authors conducted independent literature-based signal assessments. This created redundancy and, more critically, gaps where signals identified in one workflow were not consistently reflected in the other. A 2023 internal audit found that 12% of signals evaluated by the signal management team were not referenced in the corresponding product's most recent PSUR.</p>
            <p><strong>Escalating costs with no scalability path.</strong> Novartis's pipeline included 40+ late-stage assets expected to reach market within five years, each of which would add PSUR obligations upon approval. The existing manual model would have required hiring an additional 25-30 FTEs to accommodate portfolio growth, at an incremental cost of $6-8M annually, with a 12-18 month recruitment and training cycle for qualified pharmacovigilance professionals in a highly competitive labor market.</p>
          </div>
        </div>
      </div>
    </section>

    <!-- ================================================================
         SECTION 6: OUR APPROACH / SOLUTION
         ================================================================ -->
    <div class="arca-section-divider" aria-hidden="true"></div>

    <section class="arca-bg-grey-50 arca-bg-mesh" style="padding: var(--space-9) 0;" data-animate>
      <div style="max-width: var(--content-max-width); margin: 0 auto; padding: 0 24px;">
        <h2 class="arca-heading-1" style="margin-bottom: var(--space-7);">
          The ArcaScience Solution
        </h2>

        <div style="display: grid; grid-template-columns: 7fr 5fr; gap: 48px; align-items: start;">

          <!-- Left: Approach description -->
          <div>
            <div class="arca-body-lg" style="color: var(--grey-700); line-height: 1.75;">
              <p>ArcaScience deployed a portfolio-wide PSUR automation platform that integrated directly with Novartis's existing pharmacovigilance infrastructure. The implementation was executed in four phases over 24 weeks, beginning with a 10-product pilot and scaling to the full portfolio of 300+ products.</p>

              <h3 class="arca-heading-3" style="margin-top: var(--space-6); margin-bottom: var(--space-3);">Phase 1: Data Layer Integration</h3>
              <p>The ArcaScience Data Intelligence Engine was connected to Novartis's Argus safety database via validated API, establishing automated extraction of ICSRs, follow-up reports, and case narratives. Parallel connections were established to the Novartis Clinical Trial Results Database, post-authorization study repositories, and risk management plan tracking systems. The platform automatically calculated interval and cumulative case counts, patient exposure estimates (using both clinical trial enrollment data and commercial sales-based exposure algorithms), and reporting rates by MedDRA System Organ Class, High-Level Term, and Preferred Term.</p>

              <h3 class="arca-heading-3" style="margin-top: var(--space-6); margin-bottom: var(--space-3);">Phase 2: Automated PSUR Content Generation</h3>
              <p>ArcaScience's Regulatory Outputs module was configured to generate complete PSUR/PBRER documents following the ICH E2C(R2) template structure. For each product, the system automatically produced: worldwide marketing authorization status tables, estimated patient exposure calculations with methodology documentation, summary tabulations of serious adverse events by SOC and PT, interval and cumulative line listings, signal evaluation summaries cross-referenced with the signal management database, and benefit-risk analysis sections using standardized MCDA frameworks. Medical writers reviewed and refined the AI-generated content rather than authoring from scratch, shifting their role from document creation to quality assurance.</p>

              <h3 class="arca-heading-3" style="margin-top: var(--space-6); margin-bottom: var(--space-3);">Phase 3: Portfolio-Wide Signal Detection Dashboard</h3>
              <p>The Decision Intelligence module deployed a unified signal detection dashboard that ran continuous disproportionality analyses across the entire portfolio simultaneously. The dashboard applied product-specific expected event profiles, adjusting signal thresholds based on each drug's mechanism of action and known class effects. For Cosentyx, the system monitored immunosuppression-related signals including serious infections, malignancies, and inflammatory bowel disease exacerbation. For Entresto, it tracked hypotension, hyperkalemia, and angioedema against historical ACEI/ARB class rates. Cross-product signal correlation identified potential class effects early, flagging them for multi-product PSUR coordination.</p>

              <h3 class="arca-heading-3" style="margin-top: var(--space-6); margin-bottom: var(--space-3);">Phase 4: Portfolio Orchestration & Deadline Management</h3>
              <p>The platform implemented an intelligent scheduling system that tracked all 150+ PSUR deadlines, automatically initiated data lock points 8 weeks before each submission date, assigned workflow tasks to pharmacovigilance scientists and medical writers, and escalated overdue tasks to team leads. A portfolio-level dashboard provided GDS leadership with real-time visibility into the status of every active PSUR, resource allocation across therapeutic areas, and predictive deadline risk scoring based on historical completion patterns.</p>
            </div>
          </div>

          <!-- Right: Sidebar card -->
          <div>
            <div class="arca-card" style="position: sticky; top: calc(var(--nav-height) + 24px);">
              <h3 class="arca-heading-3" style="margin-bottom: var(--space-4);">Platform Modules Used</h3>
              <div style="display: flex; flex-direction: column; gap: 8px; margin-bottom: var(--space-5);">
                <span class="arca-module-tag is-data">Data Intelligence Engine</span>
                <span class="arca-module-tag is-analytics">Decision Intelligence</span>
                <span class="arca-module-tag is-output">Regulatory Outputs</span>
                <span class="arca-module-tag is-output">PSUR Automation Module</span>
                <span class="arca-module-tag is-analytics">Signal Detection Dashboard</span>
                <span class="arca-module-tag is-data">Portfolio Orchestration</span>
              </div>

              <div style="border-top: 1px solid var(--grey-200); padding-top: var(--space-5); margin-bottom: var(--space-5);">
                <p class="arca-label arca-text-grey-600" style="margin-bottom: var(--space-2);">Implementation Timeline</p>
                <p class="arca-heading-2">24 weeks</p>
                <p class="arca-body-sm arca-text-grey-600" style="margin-top: var(--space-1);">10-product pilot + full portfolio rollout</p>
              </div>

              <div style="border-top: 1px solid var(--grey-200); padding-top: var(--space-5); margin-bottom: var(--space-5);">
                <p class="arca-label arca-text-grey-600" style="margin-bottom: var(--space-2);">Key Products</p>
                <p class="arca-body-sm" style="font-weight: 600;">Cosentyx (secukinumab)</p>
                <p class="arca-body-sm" style="font-weight: 600;">Entresto (sacubitril/valsartan)</p>
                <p class="arca-body-sm" style="font-weight: 600;">Kisqali (ribociclib)</p>
                <p class="arca-body-sm" style="font-weight: 600;">Kesimpta (ofatumumab)</p>
                <p class="arca-body-sm" style="font-weight: 600;">Pluvicto (lutetium Lu 177 vipivotide)</p>
                <p class="arca-body-sm arca-text-grey-600" style="margin-top: var(--space-1);">+ 295 additional marketed products</p>
              </div>

              <div style="border-top: 1px solid var(--grey-200); padding-top: var(--space-5);">
                <p class="arca-label arca-text-grey-600" style="margin-bottom: var(--space-2);">Regulatory Jurisdictions</p>
                <p class="arca-body-sm arca-text-grey-600">FDA, EMA, Swissmedic, PMDA, NMPA, Health Canada, TGA, ANVISA, SAHPRA, and 60+ additional markets</p>
              </div>
            </div>
          </div>

        </div>
      </div>
    </section>

    <!-- ================================================================
         SECTION 7: RESULTS & IMPACT
         ================================================================ -->
    <section style="padding: var(--space-9) 0;" data-animate>
      <div style="max-width: var(--content-max-width); margin: 0 auto; padding: 0 24px;">
        <h2 class="arca-heading-1" style="margin-bottom: var(--space-7);">
          Results & Impact
        </h2>

        <div style="display: grid; grid-template-columns: repeat(2, 1fr); gap: 24px;">

          <div class="arca-card" data-animate>
            <span class="arca-stat-lg" style="color: var(--blue-600); display: block; margin-bottom: var(--space-3);" data-countup="60" data-countup-suffix="%">60%</span>
            <h3 class="arca-heading-3" style="margin-bottom: var(--space-2);">PSUR Preparation Time Reduction</h3>
            <p class="arca-body-sm arca-text-grey-600">
              Average PSUR preparation time decreased from 6-8 weeks to 2.5-3 weeks across the portfolio. For high-volume products like Cosentyx and Entresto, the reduction was even more pronounced: data compilation that previously required 3-4 weeks was completed in 2-3 days through automated extraction and tabulation. Medical writers now spend their time on clinical interpretation and quality review rather than document assembly and data formatting.
            </p>
          </div>

          <div class="arca-card" data-animate>
            <span class="arca-stat-lg" style="color: var(--teal-600); display: block; margin-bottom: var(--space-3);" data-countup="0">0</span>
            <h3 class="arca-heading-3" style="margin-bottom: var(--space-2);">Regulatory Deadline Misses</h3>
            <p class="arca-body-sm arca-text-grey-600">
              In the 18 months since full deployment, Novartis has achieved a 100% on-time submission rate across all 150+ annual PSURs. The intelligent scheduling system provides 12-week advance visibility into upcoming deadlines, automatic resource allocation based on product complexity scores, and real-time escalation when milestones are at risk. The previous pattern of emergency weekend staffing to meet tight deadlines has been entirely eliminated.
            </p>
          </div>

          <div class="arca-card" data-animate>
            <span class="arca-stat-lg" style="color: var(--indigo-600); display: block; margin-bottom: var(--space-3);" data-countup="12" data-countup-prefix="$" data-countup-suffix="M">$12M</span>
            <h3 class="arca-heading-3" style="margin-bottom: var(--space-2);">Annual Cost Savings</h3>
            <p class="arca-body-sm arca-text-grey-600">
              The automation platform reduced direct PSUR-related labor costs by $8.4M annually (equivalent to 42 FTEs redeployed to higher-value pharmacovigilance activities including signal evaluation and risk management) and eliminated $3.6M in external medical writing and biostatistics vendor fees. The total $12M annual savings represents a 60% reduction from the pre-implementation baseline of $20M. Return on investment was achieved within 14 months of the initial deployment.
            </p>
          </div>

          <div class="arca-card" data-animate>
            <span class="arca-stat-lg" style="color: var(--green-600); display: block; margin-bottom: var(--space-3);" data-countup="45" data-countup-suffix="%">45%</span>
            <h3 class="arca-heading-3" style="margin-bottom: var(--space-2);">Improvement in PRAC Assessment Outcomes</h3>
            <p class="arca-body-sm arca-text-grey-600">
              EMA PRAC assessment outcomes improved significantly following the standardization of benefit-risk analysis across the portfolio. The proportion of PSURs receiving "no regulatory action" increased from 62% to 90%, while the rate of major objections requiring supplementary data submissions decreased by 45%. Assessors specifically commended the consistent quantitative benefit-risk framework and the comprehensive signal evaluation cross-referencing in multiple assessment reports.
            </p>
          </div>

        </div>
      </div>
    </section>

    <!-- ================================================================
         SECTION 8: CLIENT TESTIMONIAL
         ================================================================ -->
    <section class="arca-bg-blue-50" style="padding: var(--space-9) 0;" data-animate>
      <div style="max-width: var(--content-max-width); margin: 0 auto; padding: 0 24px;">
        <div style="max-width: 840px; margin: 0 auto;">

          <div class="arca-testimonial">
            <blockquote style="border-left: 3px solid var(--blue-400); padding-left: 32px; margin: 0;">
              <p style="font-family: var(--font-serif); font-style: italic; font-size: 1.5rem; line-height: 1.6; color: var(--grey-900);">
                "The PSUR process had become our organization's single largest operational bottleneck. With 150 reports due annually and a portfolio that keeps growing, we were running out of headroom. ArcaScience didn't just automate the paperwork &mdash; they gave us a fundamentally different operating model. Our pharmacovigilance scientists are now spending their time on the science: evaluating signals, interpreting benefit-risk data, and making decisions that matter for patient safety. The $12 million in annual savings is significant, but the real value is that we can now scale our portfolio without scaling our headcount proportionally. That changes the economics of pharmacovigilance entirely."
              </p>
            </blockquote>

            <div class="arca-testimonial-attribution" style="margin-top: var(--space-6); padding-left: 32px;">
              <p class="arca-body-md" style="font-weight: 600; margin-bottom: var(--space-1);">Dr. Marcus Ehrenberg</p>
              <p class="arca-body-sm arca-text-grey-600">Senior Vice President, Global Drug Safety Operations</p>
              <p class="arca-body-sm arca-text-grey-600">Novartis Pharma AG &mdash; Basel, Switzerland</p>
            </div>
          </div>

        </div>
      </div>
    </section>

    <!-- ================================================================
         SECTION 9: TECHNICAL DETAILS
         ================================================================ -->
    <section style="padding: var(--space-9) 0;" data-animate>
      <div style="max-width: var(--content-max-width); margin: 0 auto; padding: 0 24px;">
        <div style="max-width: 840px; margin: 0 auto;">
          <h2 class="arca-heading-1" style="margin-bottom: var(--space-7);">
            Technical Details
          </h2>

          <div data-accordion>

            <!-- Accordion Item 1: Data Sources -->
            <div class="arca-card" style="margin-bottom: var(--space-4);" data-accordion-item>
              <div style="display: flex; justify-content: space-between; align-items: center; cursor: pointer;" data-accordion-trigger>
                <h3 class="arca-heading-3">Data Sources &amp; Integration Architecture</h3>
                <svg width="20" height="20" viewBox="0 0 20 20" fill="none" style="transition: transform 0.3s ease;" data-accordion-icon>
                  <path d="M5 7.5L10 12.5L15 7.5" stroke="currentColor" stroke-width="1.5" stroke-linecap="round" stroke-linejoin="round"/>
                </svg>
              </div>
              <div style="max-height: 0; overflow: hidden; transition: max-height 0.3s ease;" data-accordion-content>
                <div style="padding-top: var(--space-4); color: var(--grey-700);">
                  <ul style="list-style: disc; padding-left: 24px; line-height: 1.75;">
                    <li><strong>Argus Safety Database:</strong> Validated API integration for real-time extraction of ICSRs, follow-up reports, and case narratives across 300+ products (2.8M+ cumulative cases)</li>
                    <li><strong>Novartis Clinical Trial Results Database:</strong> Patient-level safety data from 1,200+ completed and ongoing clinical trials with automated CIOMS form generation</li>
                    <li><strong>Post-Authorization Safety Studies (PASS):</strong> Integrated results from 45+ active PASS studies required by EMA risk management plans</li>
                    <li><strong>Risk Management Plan Tracking:</strong> Effectiveness measures from additional risk minimization measures (aRMM) including HCP surveys, patient registries, and educational material distribution metrics</li>
                    <li><strong>FAERS &amp; EudraVigilance:</strong> External spontaneous reporting databases for comparator and class-level signal contextualization</li>
                    <li><strong>Published Literature:</strong> Automated PubMed and Embase monitoring with NLP-based relevance scoring and adverse event extraction from 15,000+ publications per PSUR cycle</li>
                    <li><strong>Commercial Sales Data:</strong> IMS Health/IQVIA prescription data for patient exposure estimation using defined daily dose (DDD) methodology</li>
                  </ul>
                </div>
              </div>
            </div>

            <!-- Accordion Item 2: AI Models Applied -->
            <div class="arca-card" style="margin-bottom: var(--space-4);" data-accordion-item>
              <div style="display: flex; justify-content: space-between; align-items: center; cursor: pointer;" data-accordion-trigger>
                <h3 class="arca-heading-3">AI Models &amp; Automation Capabilities</h3>
                <svg width="20" height="20" viewBox="0 0 20 20" fill="none" style="transition: transform 0.3s ease;" data-accordion-icon>
                  <path d="M5 7.5L10 12.5L15 7.5" stroke="currentColor" stroke-width="1.5" stroke-linecap="round" stroke-linejoin="round"/>
                </svg>
              </div>
              <div style="max-height: 0; overflow: hidden; transition: max-height 0.3s ease;" data-accordion-content>
                <div style="padding-top: var(--space-4); color: var(--grey-700);">
                  <ul style="list-style: disc; padding-left: 24px; line-height: 1.75;">
                    <li><strong>Automated Tabulation Engine:</strong> Generates summary tabulations of serious and non-serious adverse events by SOC, HLGT, HLT, and PT with interval/cumulative breakdowns, reporting rates per 100 patient-years, and MedDRA version-controlled coding</li>
                    <li><strong>Exposure Estimation Models (n=3):</strong> Clinical trial enrollment-based, commercial sales-based (DDD method), and hybrid models with documented methodology for each product</li>
                    <li><strong>Signal Detection Suite (n=6):</strong> PRR, ROR, BCPNN, MGPS, temporal scan statistics, and tree-based scan statistics with product-specific expected event profile adjustment</li>
                    <li><strong>NLP Literature Models (n=4):</strong> Relevance classification (F1: 0.93), adverse event extraction (F1: 0.91), causal assessment classification, and study quality scoring</li>
                    <li><strong>Document Generation Models (n=3):</strong> ICH E2C(R2)-compliant section generation with product-specific context, regulatory history awareness, and previous cycle cross-referencing</li>
                    <li><strong>Benefit-Risk Synthesis Models (n=4):</strong> MCDA frameworks with standardized criteria sets by therapeutic area, swing weighting, stochastic sensitivity analysis, and effects table generation</li>
                    <li><strong>Cross-Product Signal Correlation:</strong> Identifies potential class effects by detecting correlated signals across products sharing the same mechanism of action or therapeutic target</li>
                  </ul>
                </div>
              </div>
            </div>

            <!-- Accordion Item 3: Validation Methodology -->
            <div class="arca-card" style="margin-bottom: var(--space-4);" data-accordion-item>
              <div style="display: flex; justify-content: space-between; align-items: center; cursor: pointer;" data-accordion-trigger>
                <h3 class="arca-heading-3">Validation &amp; Quality Assurance</h3>
                <svg width="20" height="20" viewBox="0 0 20 20" fill="none" style="transition: transform 0.3s ease;" data-accordion-icon>
                  <path d="M5 7.5L10 12.5L15 7.5" stroke="currentColor" stroke-width="1.5" stroke-linecap="round" stroke-linejoin="round"/>
                </svg>
              </div>
              <div style="max-height: 0; overflow: hidden; transition: max-height 0.3s ease;" data-accordion-content>
                <div style="padding-top: var(--space-4); color: var(--grey-700);">
                  <p style="margin-bottom: var(--space-3);">The portfolio-wide deployment was validated under Novartis's GxP Computerized Systems Validation framework with the following controls:</p>
                  <ul style="list-style: disc; padding-left: 24px; line-height: 1.75;">
                    <li><strong>GAMP 5 Category 5 Validation:</strong> Complete validation lifecycle with risk-based testing strategy, including 2,400+ test cases covering all product types and therapeutic areas</li>
                    <li><strong>Data Reconciliation:</strong> Automated comparison of ArcaScience-generated tabulations against manual Argus queries for 100% of products during the first two PSUR cycles (0.02% discrepancy rate, all attributable to timing differences in data lock point execution)</li>
                    <li><strong>Medical Review Workflow:</strong> All AI-generated content passes through a mandatory pharmacovigilance scientist review before finalization, with tracked changes and approval workflow compliant with 21 CFR Part 11</li>
                    <li><strong>Model Performance Monitoring:</strong> Continuous monitoring of NLP extraction accuracy, signal detection sensitivity/specificity, and document generation quality scores with quarterly revalidation against expert-labeled gold standards</li>
                    <li><strong>Audit Trail:</strong> Complete data lineage from source system record to final PSUR section, with version-controlled document history and electronic signatures</li>
                    <li><strong>SOC 2 Type II Certification:</strong> ArcaScience platform certified for security, availability, processing integrity, confidentiality, and privacy</li>
                  </ul>
                </div>
              </div>
            </div>

            <!-- Accordion Item 4: Regulatory Context -->
            <div class="arca-card" data-accordion-item>
              <div style="display: flex; justify-content: space-between; align-items: center; cursor: pointer;" data-accordion-trigger>
                <h3 class="arca-heading-3">Regulatory Context &amp; Compliance</h3>
                <svg width="20" height="20" viewBox="0 0 20 20" fill="none" style="transition: transform 0.3s ease;" data-accordion-icon>
                  <path d="M5 7.5L10 12.5L15 7.5" stroke="currentColor" stroke-width="1.5" stroke-linecap="round" stroke-linejoin="round"/>
                </svg>
              </div>
              <div style="max-height: 0; overflow: hidden; transition: max-height 0.3s ease;" data-accordion-content>
                <div style="padding-top: var(--space-4); color: var(--grey-700);">
                  <p style="margin-bottom: var(--space-3);">The PSUR automation platform was designed to comply with all relevant regulatory frameworks:</p>
                  <ul style="list-style: disc; padding-left: 24px; line-height: 1.75;">
                    <li><strong>ICH E2C(R2):</strong> All generated PSURs/PBRERs follow the standardized format and content requirements including worldwide marketing authorization status, patient exposure, summary tabulations, signal evaluation, benefit-risk analysis, and integrated benefit-risk evaluation</li>
                    <li><strong>EMA GVP Module VII:</strong> Compliance with EU requirements for periodic safety update reports, including EURD list scheduling and data lock point management</li>
                    <li><strong>EMA GVP Module IX:</strong> Signal management integration ensuring bidirectional cross-referencing between signal evaluation and periodic reporting workflows</li>
                    <li><strong>FDA IND Safety Reporting (21 CFR 312.32):</strong> Parallel compliance with US periodic reporting requirements for products with active INDs</li>
                    <li><strong>ICH E2E:</strong> Pharmacovigilance planning integration for newly approved products with evolving safety profiles</li>
                    <li><strong>EURD List Compliance:</strong> Automated scheduling against the European Union Reference Date list with support for worksharing procedures and single assessment procedures</li>
                    <li><strong>Outcome:</strong> In the first full year of operation, 100% of PSURs were submitted on time. PRAC assessment outcomes improved from 62% "no regulatory action" to 90%. Zero major objections related to data completeness or benefit-risk methodology. Three PRAC assessment reports specifically noted the "comprehensive and well-structured" benefit-risk evaluation approach.</li>
                  </ul>
                </div>
              </div>
            </div>

          </div>
        </div>
      </div>
    </section>

    <!-- ================================================================
         SECTION 10: RELATED CASE STUDIES
         ================================================================ -->
    <div class="arca-section-divider" aria-hidden="true"></div>

    <section class="arca-bg-grey-50 arca-bg-mesh" style="padding: var(--space-9) 0;" data-animate>
      <div style="max-width: var(--content-max-width); margin: 0 auto; padding: 0 24px;">
        <h2 class="arca-heading-1" style="margin-bottom: var(--space-7);">
          Related Case Studies
        </h2>

        <div style="display: grid; grid-template-columns: repeat(3, 1fr); gap: 24px;">

          <!-- Related Case Study 1 -->
          <a href="/case-study-astrazeneca" class="arca-card" style="text-decoration: none; color: inherit; display: block;" data-animate>
            <div style="aspect-ratio: 16/9; border-radius: 4px; margin-bottom: var(--space-4); overflow: hidden;">
              <svg viewBox="0 0 400 225" fill="none" xmlns="http://www.w3.org/2000/svg" aria-hidden="true" style="width: 100%; height: 100%; display: block;"><defs><linearGradient id="az-c4" x1="0" y1="0" x2="400" y2="225" gradientUnits="userSpaceOnUse"><stop offset="0%" stop-color="#0F2B46"/><stop offset="100%" stop-color="#0D3B5E"/></linearGradient></defs><rect width="400" height="225" fill="url(#az-c4)"/><line x1="120" y1="70" x2="200" y2="112" stroke="#0D7C6B" stroke-width="1.5" opacity="0.5"/><line x1="200" y1="112" x2="280" y2="80" stroke="#3B7DD8" stroke-width="1.5" opacity="0.5"/><line x1="200" y1="112" x2="160" y2="160" stroke="#0D7C6B" stroke-width="1.5" opacity="0.5"/><line x1="200" y1="112" x2="300" y2="150" stroke="#3B7DD8" stroke-width="1.5" opacity="0.4"/><line x1="280" y1="80" x2="340" y2="112" stroke="#0D7C6B" stroke-width="1.5" opacity="0.4"/><circle cx="200" cy="112" r="10" fill="#0D7C6B" opacity="0.8"/><circle cx="200" cy="112" r="18" fill="none" stroke="#0D7C6B" stroke-width="1" opacity="0.3"/><circle cx="120" cy="70" r="7" fill="#3B7DD8" opacity="0.7"/><circle cx="280" cy="80" r="8" fill="#3B7DD8" opacity="0.7"/><circle cx="160" cy="160" r="6" fill="#0D7C6B" opacity="0.6"/><circle cx="300" cy="150" r="7" fill="#3B7DD8" opacity="0.6"/><circle cx="340" cy="112" r="5" fill="#0D7C6B" opacity="0.5"/></svg>
            </div>
            <h3 class="arca-heading-3" style="margin-bottom: var(--space-2);">Accelerated Oncology BRA for Regulatory Submission</h3>
            <p class="arca-body-sm arca-text-grey-600" style="margin-bottom: var(--space-3);">AstraZeneca</p>
            <p class="arca-stat-sm" style="color: var(--blue-600);">3x faster regulatory submission</p>
          </a>

          <!-- Related Case Study 2 -->
          <a href="/case-study-sanofi" class="arca-card" style="text-decoration: none; color: inherit; display: block;" data-animate>
            <div style="aspect-ratio: 16/9; border-radius: 4px; margin-bottom: var(--space-4); overflow: hidden;">
              <svg viewBox="0 0 400 225" fill="none" xmlns="http://www.w3.org/2000/svg" aria-hidden="true" style="width: 100%; height: 100%; display: block;"><defs><linearGradient id="sn-c4" x1="0" y1="0" x2="400" y2="225" gradientUnits="userSpaceOnUse"><stop offset="0%" stop-color="#1A1145"/><stop offset="100%" stop-color="#0F2B5E"/></linearGradient></defs><rect width="400" height="225" fill="url(#sn-c4)"/><line x1="200" y1="30" x2="200" y2="70" stroke="#4338CA" stroke-width="2.5" opacity="0.7"/><line x1="200" y1="70" x2="120" y2="100" stroke="#4338CA" stroke-width="2" opacity="0.6"/><line x1="200" y1="70" x2="280" y2="100" stroke="#3B7DD8" stroke-width="2" opacity="0.6"/><line x1="120" y1="100" x2="70" y2="140" stroke="#4338CA" stroke-width="1.5" opacity="0.5"/><line x1="120" y1="100" x2="150" y2="140" stroke="#4338CA" stroke-width="1.5" opacity="0.5"/><line x1="280" y1="100" x2="240" y2="140" stroke="#3B7DD8" stroke-width="1.5" opacity="0.5"/><line x1="280" y1="100" x2="320" y2="140" stroke="#3B7DD8" stroke-width="1.5" opacity="0.5"/><circle cx="200" cy="30" r="5" fill="#4338CA" opacity="0.8"/><circle cx="200" cy="70" r="6" fill="#4338CA" opacity="0.7"/><circle cx="120" cy="100" r="5" fill="#4338CA" opacity="0.65"/><circle cx="280" cy="100" r="5" fill="#3B7DD8" opacity="0.65"/><circle cx="70" cy="140" r="4" fill="#4338CA" opacity="0.55"/><circle cx="150" cy="140" r="4" fill="#4338CA" opacity="0.55"/><circle cx="240" cy="140" r="4" fill="#3B7DD8" opacity="0.55"/><circle cx="320" cy="140" r="4" fill="#3B7DD8" opacity="0.55"/></svg>
            </div>
            <h3 class="arca-heading-3" style="margin-bottom: var(--space-2);">Portfolio-Wide Signal Management Transformation</h3>
            <p class="arca-body-sm arca-text-grey-600" style="margin-bottom: var(--space-3);">Sanofi</p>
            <p class="arca-stat-sm" style="color: var(--blue-600);">Unified signal management across 200+ products</p>
          </a>

          <!-- Related Case Study 3 -->
          <a href="/case-study-icon" class="arca-card" style="text-decoration: none; color: inherit; display: block;" data-animate>
            <div style="aspect-ratio: 16/9; border-radius: 4px; margin-bottom: var(--space-4); overflow: hidden;">
              <svg viewBox="0 0 400 225" fill="none" xmlns="http://www.w3.org/2000/svg" aria-hidden="true" style="width: 100%; height: 100%; display: block;"><defs><linearGradient id="ic-c4" x1="0" y1="0" x2="400" y2="225" gradientUnits="userSpaceOnUse"><stop offset="0%" stop-color="#0F1E3D"/><stop offset="100%" stop-color="#1A2850"/></linearGradient><linearGradient id="ic-cb4" x1="0" y1="1" x2="0" y2="0"><stop offset="0%" stop-color="#3B7DD8" stop-opacity="0.3"/><stop offset="100%" stop-color="#3B7DD8" stop-opacity="0.7"/></linearGradient></defs><rect width="400" height="225" fill="url(#ic-c4)"/><line x1="55" y1="25" x2="55" y2="185" stroke="#3B7DD8" stroke-width="1" opacity="0.25"/><line x1="55" y1="185" x2="380" y2="185" stroke="#3B7DD8" stroke-width="1" opacity="0.25"/><rect x="75" y="160" width="30" height="25" rx="2" fill="url(#ic-cb4)"/><rect x="120" y="145" width="30" height="40" rx="2" fill="url(#ic-cb4)"/><rect x="165" y="130" width="30" height="55" rx="2" fill="url(#ic-cb4)"/><rect x="210" y="110" width="30" height="75" rx="2" fill="url(#ic-cb4)"/><rect x="255" y="88" width="30" height="97" rx="2" fill="url(#ic-cb4)"/><rect x="300" y="65" width="30" height="120" rx="2" fill="url(#ic-cb4)"/><rect x="345" y="48" width="30" height="137" rx="2" fill="url(#ic-cb4)"/><polyline points="90,155 135,140 180,125 225,105 270,82 315,60 360,42" stroke="#4338CA" stroke-width="2" fill="none" stroke-linecap="round" opacity="0.7"/><circle cx="360" cy="42" r="4" fill="#4338CA" opacity="0.9"/></svg>
            </div>
            <h3 class="arca-heading-3" style="margin-bottom: var(--space-2);">CRO Safety Reporting Standardization</h3>
            <p class="arca-body-sm arca-text-grey-600" style="margin-bottom: var(--space-3);">ICON plc</p>
            <p class="arca-stat-sm" style="color: var(--blue-600);">$8M annual savings across 40 sponsors</p>
          </a>

        </div>
      </div>
    </section>

    <!-- ================================================================
         SECTION 11: CTA
         ================================================================ -->
    <section class="arca-cta-section" data-animate style="position: relative; overflow: hidden;">

      <!-- arca-decor: CTA glow orbs -->
      <div style="position: absolute; top: -60px; left: -60px; width: 300px; height: 300px; background: radial-gradient(circle, rgba(255,255,255,0.08) 0%, transparent 70%); border-radius: 50%; filter: blur(40px); pointer-events: none; animation: as-float 7s ease-in-out infinite; z-index: 0;"></div>
      <div style="position: absolute; bottom: -40px; right: -40px; width: 250px; height: 250px; background: radial-gradient(circle, rgba(255,255,255,0.06) 0%, transparent 70%); border-radius: 50%; filter: blur(40px); pointer-events: none; animation: as-float 9s ease-in-out infinite reverse; z-index: 0;"></div>

      <div style="position: relative; z-index: 1; max-width: 680px; margin: 0 auto; padding: 0 24px;">
        <h2 class="arca-heading-1" style="margin-bottom: var(--space-5);">
          Automate Your PSUR Process &amp; Scale Your Portfolio
        </h2>
        <p class="arca-body-lg" style="margin-bottom: var(--space-7);">
          See how ArcaScience can transform your periodic safety reporting from a resource bottleneck into a scalable, AI-powered workflow. Talk to a scientist about your portfolio's PSUR automation potential.
        </p>
        <div style="display: flex; gap: 16px; justify-content: center; flex-wrap: wrap;">
          <a href="/contact" class="arca-btn-primary-inverted">
            Talk to a Scientist
          </a>
          <a href="/downloads/case-studies/case-study-novartis-psur-automation.pdf" class="arca-btn-secondary" style="border-color: rgba(255,255,255,0.3); color: var(--white);" target="_blank" rel="noopener">
            Download PDF <span aria-hidden="true">&darr;</span>
          </a>
        </div>
      </div>
    </section>

  </main>

  <!-- ================================================================
       FOOTER
       ================================================================ -->
  <footer class="arca-bg-blue-900" style="padding: var(--space-9) 0 var(--space-7);">
    <div style="max-width: var(--content-max-width); margin: 0 auto; padding: 0 24px;">
      <div style="display: grid; grid-template-columns: 2fr 1fr 1fr 1fr 1fr; gap: 48px;">

        <!-- Column 1: Brand -->
        <div>
          <img src="/images/arcascience-logo-white.svg" alt="ArcaScience" height="28" style="margin-bottom: var(--space-5);">
          <p class="arca-body-sm" style="color: rgba(255,255,255,0.65); max-width: 280px;">
            AI-driven benefit-risk analysis for pharmaceutical development. Founded 2018.
          </p>
        </div>

        <!-- Column 2: Platform -->
        <div>
          <p class="arca-label" style="color: rgba(255,255,255,0.45); margin-bottom: var(--space-4);">Platform</p>
          <nav style="display: flex; flex-direction: column; gap: 12px;">
            <a href="/platform-overview" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Overview</a>
            <a href="/platform-data-intelligence" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Data Intelligence</a>
            <a href="/platform-ai-models" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Decision Intelligence</a>
            <a href="/platform-outputs" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Regulatory Outputs</a>
            <a href="/security-compliance" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Security & Compliance</a>
          </nav>
        </div>

        <!-- Column 3: Solutions -->
        <div>
          <p class="arca-label" style="color: rgba(255,255,255,0.45); margin-bottom: var(--space-4);">Solutions</p>
          <nav style="display: flex; flex-direction: column; gap: 12px;">
            <a href="/solution-therapeutic-area" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Therapeutic Areas</a>
            <a href="/ta-oncology" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Oncology</a>
            <a href="/ta-neurology" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Neurology</a>
            <a href="/ta-immunology" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Immunology</a>
            <a href="/ta-cardiology" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Cardiology</a>
            <a href="/ta-respiratory" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Respiratory</a>
            <a href="/ta-rare-diseases" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Rare Diseases</a>
            <a href="/ta-dermatology" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Dermatology</a>
            <a href="/ta-hematology" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Hematology</a>
          </nav>
        </div>

        <!-- Column 4: Company -->
        <div>
          <p class="arca-label" style="color: rgba(255,255,255,0.45); margin-bottom: var(--space-4);">Company</p>
          <nav style="display: flex; flex-direction: column; gap: 12px;">
            <a href="/about" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">About</a>
            <a href="/leadership" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Team</a>
            <a href="/careers" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Careers</a>
            <a href="/about" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">News</a>
            <a href="/contact" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Contact</a>
          </nav>
        </div>

        <!-- Column 5: Resources -->
        <div>
          <p class="arca-label" style="color: rgba(255,255,255,0.45); margin-bottom: var(--space-4);">Resources</p>
          <nav style="display: flex; flex-direction: column; gap: 12px;">
            <a href="/evidence-case-studies-hub" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Case Studies</a>
            <a href="/resources-whitepapers" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Whitepapers</a>
            <a href="/resources" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Blog</a>
            <a href="/resources" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Documentation</a>
          </nav>
        </div>

      </div>

      <!-- Footer bottom -->
      <div style="margin-top: var(--space-8); padding-top: var(--space-5); border-top: 1px solid rgba(255,255,255,0.1); display: flex; justify-content: space-between; align-items: center;">
        <p class="arca-caption" style="color: rgba(255,255,255,0.45);">
          &copy; 2026 ArcaScience. All rights reserved.
        </p>
        <div style="display: flex; gap: 24px;">
          <a href="/legal-privacy" style="color: rgba(255,255,255,0.45); text-decoration: none; font-size: 0.75rem;">Privacy</a>
          <a href="/legal-terms" style="color: rgba(255,255,255,0.45); text-decoration: none; font-size: 0.75rem;">Terms</a>
          <a href="/legal-cookies" style="color: rgba(255,255,255,0.45); text-decoration: none; font-size: 0.75rem;">Cookies</a>
          <a href="/legal-accessibility" style="color: rgba(255,255,255,0.45); text-decoration: none; font-size: 0.75rem;">Accessibility</a>
        </div>
      </div>
    </div>
  </footer>

  <!-- Back to top button -->
  <button data-back-to-top aria-label="Back to top">
    <svg width="16" height="16" viewBox="0 0 16 16" fill="none"><path d="M8 12V4M4 7l4-4 4 4" stroke="currentColor" stroke-width="1.5" stroke-linecap="round"/></svg>
  </button>

  <!-- Global JS -->
  <script src="/dist/arcascience-global.min.js" defer></script>
  <script>
    document.addEventListener('DOMContentLoaded', function() {
      if (window.ArcaScience) ArcaScience.init();
      if (window.ArcaScienceCountUp) ArcaScienceCountUp.init({ selector: '[data-countup]' });
    });
  </script>

</body>
</html>
